Literature DB >> 28840606

High estimated prevalence of asymptomatic dengue viremia in blood donors during a dengue epidemic in southern Taiwan, 2015.

Yu-Wen Chien1,2, Yu-Chen Shu3, Kun-Ta Chuang4, Chun-Yin Yeh5, Wen-Chien Ko6, Nai-Ying Ko7, Guey-Chuen Perng8.   

Abstract

BACKGROUND: Southern Taiwan experienced a severe dengue epidemic in 2015. Adult asymptomatic cases would raise concerns on transfusion-transmitted dengue virus (DENV) infection. The aim of this study was to evaluate the magnitude of such a risk in Tainan City during this epidemic. STUDY DESIGN AND METHODS: The daily prevalence of asymptomatic dengue viremia in blood donors in Tainan City and in selected high-incidence districts during the 2015 dengue epidemic was estimated by an established mathematical model. Duration of viremia, duration of viremia before symptom onset, apparent-to-inapparent infection ratio, and reporting-to-underreporting ratio were four main parameters used in the model.
RESULTS: The estimated maximal and mean daily prevalence of asymptomatic dengue viremia in blood donors in Tainan during this dengue epidemic was 74.4 (95% confidence interval [CI], 60.8-88.0) and 15.0 (95% CI, 12.3-17.7) per 10,000, respectively. In the district with the highest incidence, the maximal and mean daily prevalence of asymptomatic viremia was 328.8 (95% CI, 271.1-386.2) and 55.3 (95% CI, 43.4-63.3) per 10,000, respectively. Approximately 234 (95% CI, 191-276) blood components containing DENV were produced during the epidemic.
CONCLUSION: Although dengue is currently not endemic in Taiwan, physicians need to be aware of the risk of transfusion-transmitted DENV infection. Our results suggest that screening measures to ensure blood safety should be evaluated and implemented during dengue epidemics even in nonendemic areas. Timely estimation of daily asymptomatic viremia prevalence by districts can help to select high-risk areas for such measures and to evaluate cost-effectiveness.
© 2017 AABB.

Entities:  

Mesh:

Year:  2017        PMID: 28840606     DOI: 10.1111/trf.14281

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

Review 1.  Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development.

Authors:  Kulkanya Chokephaibulkit; Yu-Wen Chien; Sazaly AbuBakar; Kovit Pattanapanyasat; Guey Chuen Perng
Journal:  Viruses       Date:  2020-11-05       Impact factor: 5.048

2.  Low frequency of asymptomatic dengue virus-infected donors in blood donor centers during the largest dengue outbreak in Taiwan.

Authors:  Jih-Jin Tsai; Ping-Chang Lin; Ching-Yi Tsai; Ying-Hui Wang; Li-Teh Liu
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

3.  Integrated vector management with additional pre-transmission season thermal fogging is associated with a reduction in dengue incidence in Makassar, Indonesia: Results of an 8-year observational study.

Authors:  Isra Wahid; Hasanuddin Ishak; Abdul Hafid; Muhammad Fajri; Sukmawati Sidjal; Armin Nurdin; Naisyah Tun Azikin; Rusdyah Sudirman; Hajar Hasan; Muhammad Yusuf; Imam Bachtiar; William A Hawley; Ronald Rosenberg; Neil F Lobo
Journal:  PLoS Negl Trop Dis       Date:  2019-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.